Treatment of high grade metastatic neuroendocrine tumor (mNET) with peptide receptor radionuclide therapy (PRRT): Retrospective analysis in a single referral center.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. e15175-e15175 ◽  
Author(s):  
Tannaz Armaghany ◽  
Gelareh Vahdati ◽  
Sanjay Thamake ◽  
Mohammad Hamidi ◽  
Reza Amerinia ◽  
...  
Keyword(s):  
Neuroendocrine Tumor ◽  
Retrospective Analysis ◽  
Radionuclide Therapy ◽  
Peptide Receptor Radionuclide Therapy ◽  
High Grade ◽  
Peptide Receptor ◽  
Referral Center ◽  
Metastatic Neuroendocrine Tumor

scholarly journals Efficacy of Peptide Receptor Radionuclide Therapy in a United States–Based Cohort of Metastatic Neuroendocrine Tumor Patients

Pancreas ◽  
2017 ◽  
Vol 46 (9) ◽  
pp. 1121-1126 ◽  
Author(s):  
Bryson W. Katona ◽  
Giorgio A. Roccaro ◽  
Michael C. Soulen ◽  
Yu-Xiao Yang ◽  
Bonita J. Bennett ◽  
...  
Keyword(s):  
United States ◽  
Neuroendocrine Tumor ◽  
Radionuclide Therapy ◽  
Peptide Receptor Radionuclide Therapy ◽  
Tumor Patients ◽  
Peptide Receptor ◽  
Metastatic Neuroendocrine Tumor

scholarly journals A Case of Primary Hepatic Neuroendocrine Tumor and Literature Review

2021 ◽  
pp. 90-97
Author(s):  
Pak Chiu Wong ◽  
Wong Hoi She ◽  
Ui Soon Khoo ◽  
Tan To Cheung
Keyword(s):  
Liver Resection ◽  
Neuroendocrine Tumor ◽  
Preoperative Diagnosis ◽  
Radionuclide Therapy ◽  
Tumor Recurrence ◽  
Peptide Receptor Radionuclide Therapy ◽  
Rare Tumor ◽  
Major Liver Resection ◽  
Peptide Receptor ◽  
Primary Hepatic Neuroendocrine Tumor

We report an unusual presentation of primary hepatic neuroendocrine tumor which was initially misdiagnosed as intrahepatic cholangiocarcinoma. The diagnosis was only revealed after a major liver resection by histopathology. With adjuvant lanreotide injection, the patient survived for more than 16 months after the operation without tumor recurrence. Diagnosis of this rare tumor has been a major challenge and we emphasize the importance of a preoperative diagnosis. Surgical resection remains the mainstay for curative treatment, while peptide receptor radionuclide therapy is an emerging treatment option which has provided promising results.

Sign in / Sign up

Export Citation Format

Share Document